Position in NTRA
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$814
+$215 QoQ
Shares Held
3
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#830
of 844 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Derivatives in NTRA
reported options exposure · as of Mar 31, 2025CallValue
$0
CallShares
0
PutValue
$141
PutShares
1
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Quaker Wealth Management, LLC holds $101,136 across 13 Diagnostics & Research names. NTRA ranks #7 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DGX |
Quest Diagnostics Inc
|
353 | $74,818 | |
| 2 | A |
Agilent Technologies, Inc.
|
70 | $9,298 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
12 | $6,016 | |
| 4 | DHR |
Danaher Corp /De/
|
25 | $4,762 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
1 | $1,277 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
2 | $1,052 | |
| 7 | NTRA |
Natera, Inc.
This page
|
3 | $814 | |
| 8 | WAT |
Waters Corp /De/
|
2 | $750 |
All Filings in NTRA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $814 | 3 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $599 | 3 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $687 | 3 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $482 | 3 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $506 | 3 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $141 | 1 | Put | Sole | 2025-05-29 | |
| No filing history on record for this holder in this stock. | ||||||